MCID: VLV023
MIFTS: 18

Vulvar Eccrine Porocarcinoma

Categories: Cancer diseases, Reproductive diseases

Aliases & Classifications for Vulvar Eccrine Porocarcinoma

MalaCards integrated aliases for Vulvar Eccrine Porocarcinoma:

Name: Vulvar Eccrine Porocarcinoma 12 15 70

Classifications:



External Ids:

Disease Ontology 12 DOID:7565
NCIt 50 C40306
UMLS 70 C1520081

Summaries for Vulvar Eccrine Porocarcinoma

Disease Ontology : 12 A vulva carcinoma that is characterized by heterogenous histology that includes squamous cells, mucinous cells, clear cells, pigmented cells, and spindle cells and derives from eccrine sweat glands.

MalaCards based summary : Vulvar Eccrine Porocarcinoma is related to eccrine porocarcinoma and eccrine acrospiroma. An important gene associated with Vulvar Eccrine Porocarcinoma is PIP (Prolactin Induced Protein), and among its related pathways/superpathways is Cell adhesion_Cell-matrix glycoconjugates.

Related Diseases for Vulvar Eccrine Porocarcinoma

Diseases related to Vulvar Eccrine Porocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 302, show less)
# Related Disease Score Top Affiliating Genes
1 eccrine porocarcinoma 30.4 MUC1 CEACAM5
2 eccrine acrospiroma 30.3 PIP CEACAM5
3 peritoneal serous papillary adenocarcinoma 10.3 PTGER4 PIP
4 bartholin's gland adenocarcinoma 10.2 PTGER4 PIP
5 anal canal paget's disease 10.2 PIP CDKN2A
6 apocrine adenocarcinoma 10.2 PIP MUC1
7 sebaceous adenocarcinoma 10.2 PTGER4 PIP
8 lymphocytic colitis 10.2 PTGER4 CHGA
9 anal canal carcinoma 10.1 PIP CDKN2A
10 glycogen-rich clear cell breast carcinoma 10.1 SYP PIP
11 parachordoma 10.1 MUC1 CHGA
12 solid adenocarcinoma with mucin production 10.1 MUC1 CHGA
13 subungual glomus tumor 10.1 SYP PIP
14 lobular neoplasia 10.1 PIP MUC1
15 epithelioid malignant peripheral nerve sheath tumor 10.1 MUC1 CHGA
16 malignant peritoneal mesothelioma 10.1 MUC1 CDKN2A
17 endometrial mucinous adenocarcinoma 10.1 MUC1 CDKN2A
18 primary hepatic neuroendocrine carcinoma 10.1 SYP CHGA
19 auditory system benign neoplasm 10.1 SYP CHGA
20 auditory system cancer 10.1 SYP CHGA
21 acinar cell cystadenocarcinoma 10.1 SYP CHGA
22 cauda equina neoplasm 10.1 SYP CHGA
23 gastrointestinal neuroendocrine benign tumor 10.1 SYP CHGA
24 ampulla of vater benign neoplasm 10.1 SYP CHGA
25 appendix carcinoid tumor 10.1 SYP CHGA
26 carotid body cancer 10.1 SYP CHGA
27 plasmablastic lymphoma 10.1 MUC1 CDKN2A
28 mixed ductal-endocrine carcinoma 10.1 SYP CHGA
29 gallbladder small cell carcinoma 10.1 SYP CHGA
30 ureter small cell carcinoma 10.1 SYP CHGA
31 duodenal benign neoplasm 10.1 SYP CHGA
32 urinary bladder small cell neuroendocrine carcinoma 10.1 SYP CHGA
33 breast papillary carcinoma 10.1 SYP CHGA
34 extracranial neuroblastoma 10.1 SYP CHGA
35 sensory organ benign neoplasm 10.1 SYP CHGA
36 cervical neuroblastoma 10.1 SYP CHGA
37 laryngeal neuroendocrine tumor 10.1 SYP CHGA
38 gastric neuroendocrine neoplasm 10.1 SYP CHGA
39 ovarian large-cell neuroendocrine carcinoma 10.1 SYP CHGA
40 appendix adenocarcinoma 10.1 SYP CHGA
41 gastric hemangioma 10.1 SYP CHGA
42 subependymoma 10.1 SYP CHGA
43 pineocytoma 10.1 SYP CHGA
44 cutaneous ganglioneuroma 10.1 SYP CHGA
45 ganglioneuroma 10.1 SYP CHGA
46 pancreatic gastrinoma 10.1 SYP CHGA
47 bile duct adenoma 10.1 MUC1 CDKN2A
48 cervix small cell carcinoma 10.1 SYP CHGA
49 adrenal neuroblastoma 10.1 SYP CHGA
50 adenomyoma 10.1 MUC1 CDKN2A
51 gastrointestinal neuroendocrine tumor 10.1 SYP CHGA
52 mammary paget's disease 10.1 PIP MUC1
53 carcinoid tumors, intestinal 10.1 SYP CHGA
54 ischemic fasciitis 10.1 MUC1 CDKN2A
55 endometrial small cell carcinoma 10.1 SYP CHGA
56 cholangiolocellular carcinoma 10.1 MUC1 CDKN2A
57 glomangiomatosis 10.1 SYP CHGA
58 pulmonary large cell neuroendocrine carcinoma 10.1 SYP CHGA
59 large cell neuroendocrine carcinoma 10.1 SYP CHGA
60 vaginal adenoma 10.1 SYP CHGA
61 vaginal benign neoplasm 10.1 SYP CHGA
62 carcinoid syndrome 10.1 SYP CHGA
63 binswanger's disease 10.1 SYP CHGA
64 pancreatic acinar cell adenocarcinoma 10.1 SYP CHGA
65 prostate neuroendocrine neoplasm 10.1 SYP CHGA
66 olfactory neuroblastoma 10.1 SYP CHGA
67 extra-adrenal pheochromocytoma 10.1 SYP CHGA
68 small intestine benign neoplasm 10.1 SYP CHGA
69 olfactory nerve neoplasm 10.1 SYP CHGA
70 cranial nerve malignant neoplasm 10.1 SYP CHGA
71 meckel diverticulum 10.1 SYP CHGA
72 pulmonary neuroendocrine tumor 10.1 SYP CHGA
73 sinonasal undifferentiated carcinoma 10.1 SYP MUC1
74 granulosa cell tumor of the ovary 10.1 SYP CHGA
75 papillary tumor of the pineal region 10.1 SYP MUC1
76 cranial nerve neoplasm 10.1 SYP CHGA
77 bile duct mucinous adenocarcinoma 10.1 SYP MUC1
78 acral lentiginous melanoma 10.1 MUC1 CDKN2A
79 adrenal medulla cancer 10.1 SYP CHGA
80 pleomorphic liposarcoma 10.1 MUC1 CDKN2A
81 muir-torre syndrome 10.0 PTGER4 CDKN2A
82 sarcomatoid mesothelioma 10.0 MUC1 CDKN2A
83 pulmonary sclerosing hemangioma 10.0 SYP CHGA
84 autonomic nervous system benign neoplasm 10.0 SYP CHGA
85 peripheral nervous system benign neoplasm 10.0 SYP CHGA
86 horseshoe kidney 10.0 SYP CHGA
87 pancreatic endocrine carcinoma 10.0 SYP CHGA
88 anaplastic ependymoma 10.0 SYP MUC1
89 anal paget's disease 10.0 PIP CEACAM5
90 malignant acrospiroma 10.0 PIP CEACAM5
91 fox-fordyce disease 10.0 PIP CEACAM5
92 cutaneous mucoepidermoid carcinoma 10.0 PIP CEACAM5
93 vulva adenocarcinoma 10.0 PIP CEACAM5
94 vulval paget's disease 10.0 PIP CEACAM5
95 eccrine adenocarcinoma 10.0 PIP CEACAM5
96 clear cell ependymoma 10.0 SYP MUC1
97 pleomorphic xanthoastrocytoma 10.0 SYP CHGA
98 vulvar apocrine adenocarcinoma 10.0 PIP CEACAM5
99 chordoid glioma 10.0 SYP MUC1
100 central neurocytoma 10.0 SYP CHGA
101 anal canal adenocarcinoma 10.0 PIP CEACAM5
102 nasal cavity adenocarcinoma 10.0 SYP CDKN2A
103 ovarian small cell carcinoma 10.0 SYP MUC1
104 gastric diffuse adenocarcinoma 10.0 PIP CEACAM5
105 clear cell hidradenoma 10.0 PIP CEACAM5
106 hidrocystoma 10.0 PIP CEACAM5
107 gliofibroma 10.0 SYP CDKN2A
108 malignant epithelial mesothelioma 10.0 PTGER4 CEACAM5
109 eccrine papillary adenocarcinoma 10.0 PIP CEACAM5
110 retroperitoneum carcinoma 10.0 SYP CDKN2A
111 linitis plastica 10.0 PIP CEACAM5
112 eccrine sweat gland neoplasm 10.0 PIP CEACAM5
113 cutaneous adenocystic carcinoma 10.0 PIP CEACAM5
114 cellular ependymoma 10.0 SYP MUC1
115 myxopapillary ependymoma 10.0 SYP MUC1
116 medulloepithelioma 10.0 SYP MUC1
117 malignant pheochromocytoma 10.0 SYP CHGA
118 collecting duct carcinoma 10.0 MUC1 CDKN2A
119 astroblastoma 10.0 SYP MUC1
120 apocrine sweat gland neoplasm 10.0 PIP CEACAM5
121 myxoid chondrosarcoma 10.0 SYP MUC1
122 subependymal giant cell astrocytoma 10.0 SYP CHGA
123 pericardium cancer 10.0 PTGER4 CEACAM5
124 supratentorial cancer 10.0 SYP CDKN2A
125 pulmonary blastoma 10.0 SYP CHGA
126 squamous papillomatosis 10.0 PTGER4 CEACAM5
127 gliomatosis cerebri 10.0 SYP CDKN2A
128 papilloma of choroid plexus 10.0 SYP MUC1
129 vaginal glandular tumor 10.0 CHGA CEACAM5
130 eccrine papillary adenoma 10.0 PIP CEACAM5
131 lung large cell carcinoma 10.0 SYP CHGA
132 adult teratoma 10.0 CHGA CEACAM5
133 sweat gland benign neoplasm 10.0 PIP CEACAM5
134 female urethral cancer 10.0 CHGA CEACAM5
135 pancreatic serous cystadenoma 10.0 CHGA CEACAM5
136 mesenchymal chondrosarcoma 10.0 SYP MUC1
137 appendiceal neoplasm 10.0 CHGA CEACAM5
138 sertoli-leydig cell tumor 10.0 SYP MUC1
139 hemangiopericytoma, malignant 10.0 SYP MUC1
140 cystic teratoma 10.0 SYP CDKN2A
141 villous adenoma 10.0 MUC1 CEACAM5
142 syringoma 10.0 MUC1 CEACAM5
143 large intestine lipoma 10.0 CHGA CEACAM5
144 clear cell basal cell carcinoma 10.0 CHGA CEACAM5
145 intracystic papillary adenoma 10.0 CHGA CEACAM5
146 lipoma of colon 10.0 CHGA CEACAM5
147 sertoli cell tumor 10.0 SYP MUC1
148 parotid gland adenoid cystic carcinoma 10.0 CEACAM5 CDKN2A
149 sweat gland disease 10.0 PIP CEACAM5
150 pancreatic foamy gland adenocarcinoma 10.0 MUC1 CEACAM5
151 central nervous system benign neoplasm 10.0 SYP CHGA
152 urinary bladder villous adenoma 10.0 MUC1 CEACAM5
153 intrahepatic bile duct adenoma 9.9 CHGA CEACAM5
154 bile duct cystadenocarcinoma 9.9 MUC1 CEACAM5
155 maxillary sinus benign neoplasm 9.9 CEACAM5 CDKN2A
156 colonic lymphangioma 9.9 MUC1 CEACAM5
157 well-differentiated liposarcoma 9.9 MUC1 CDKN2A
158 biliary papillomatosis 9.9 MUC1 CEACAM5
159 bile duct mucoepidermoid carcinoma 9.9 MUC1 CEACAM5
160 pancreatic mucinous cystadenoma 9.9 MUC1 CEACAM5
161 cholecystitis 9.9 MUC1 CDKN2A
162 chondroid chordoma 9.9 MUC1 CEACAM5
163 adrenal cortical adenoma 9.9 SYP CHGA
164 acute cholangitis 9.9 MUC1 CEACAM5
165 appendix disease 9.9 MUC1 CEACAM5
166 appendix cancer 9.9 MUC1 CEACAM5
167 secretory meningioma 9.9 MUC1 CEACAM5
168 pre-malignant neoplasm 9.9 PIP MUC1 CDKN2A
169 in situ carcinoma 9.9 PIP MUC1 CDKN2A
170 ovarian benign neoplasm 9.9 MUC1 CEACAM5
171 ductal carcinoma in situ 9.9 PIP MUC1 CDKN2A
172 epithelioid sarcoma 9.9 SYP MUC1
173 rectum adenocarcinoma 9.9 PIP CEACAM5
174 cavernous hemangioma 9.9 SYP MUC1
175 breast neuroendocrine neoplasm 9.9 SYP PIP CHGA
176 mucinous adenofibroma 9.9 SYP CEACAM5
177 adrenal gland disease 9.9 SYP CHGA
178 anus cancer 9.9 CEACAM5 CDKN2A
179 duodenum cancer 9.9 MUC1 CEACAM5
180 duodenum disease 9.9 MUC1 CEACAM5
181 mucinous cystadenocarcinoma 9.9 MUC1 CEACAM5
182 krukenberg carcinoma 9.9 SYP CEACAM5
183 myoblastoma 9.9 SYP CEACAM5
184 endocervical carcinoma 9.9 CEACAM5 CDKN2A
185 polycystic liver disease 1 with or without kidney cysts 9.9 MUC1 CEACAM5
186 lung leiomyosarcoma 9.9 SYP CEACAM5
187 pseudomyxoma peritonei 9.9 MUC1 CEACAM5
188 papillary adenoma 9.9 SYP CEACAM5
189 nasal cavity olfactory neuroblastoma 9.9 SYP CEACAM5
190 sex cord-gonadal stromal tumor 9.9 MUC1 CEACAM5
191 islet cell tumor 9.9 SYP CHGA
192 keratosis, seborrheic 9.9 CEACAM5 CDKN2A
193 ovarian germ cell cancer 9.9 SYP CEACAM5
194 malignant teratoma 9.9 SYP CEACAM5
195 adenocarcinoma in situ 9.9 CEACAM5 CDKN2A
196 benign mesothelioma 9.8 CEACAM5 CDKN2A
197 ganglioglioma 9.8 SYP CHGA
198 mature teratoma 9.8 SYP CEACAM5
199 pancreatic ductal carcinoma 9.8 MUC1 CDKN2A
200 breast adenocarcinoma 9.8 SYP PIP CHGA
201 endodermal sinus tumor 9.8 CHGA CEACAM5
202 esophageal neuroendocrine tumor 9.8 SYP MUC1 CHGA
203 middle ear adenoma 9.8 SYP MUC1 CHGA
204 pineoblastoma 9.8 SYP CEACAM5
205 laryngeal small cell carcinoma 9.8 SYP CHGA CDKN2A
206 chordoid meningioma 9.8 SYP MUC1 CHGA
207 dry eye syndrome 9.8 PIP MUC1
208 tonsil cancer 9.8 CEACAM5 CDKN2A
209 malignant syringoma 9.8 PTGER4 PIP CEACAM5
210 sclerosing hemangioma 9.8 SYP MUC1 CHGA
211 hemangioma 9.8 SYP MUC1 CHGA
212 clear cell meningioma 9.8 SYP MUC1 CHGA
213 microcystic adenoma 9.8 SYP MUC1 CHGA
214 eccrine sweat gland cancer 9.8 PTGER4 PIP CEACAM5
215 pancreatoblastoma 9.8 SYP MUC1 CHGA
216 basaloid squamous cell carcinoma 9.8 SYP CHGA CDKN2A
217 anus disease 9.8 CEACAM5 CDKN2A
218 respiratory system benign neoplasm 9.8 SYP CHGA CDKN2A
219 desmoplastic small round cell tumor 9.8 SYP MUC1 CHGA
220 lung benign neoplasm 9.8 SYP CHGA CDKN2A
221 reproductive organ benign neoplasm 9.8 CEACAM5 CDKN2A
222 atypical teratoid rhabdoid tumor 9.8 SYP MUC1 CHGA
223 suppression of tumorigenicity 12 9.8 SYP CHGA CDKN2A
224 mixed cell type cancer 9.8 SYP CEACAM5
225 rectal disease 9.8 CEACAM5 CDKN2A
226 papillary carcinoma 9.8 SYP MUC1 CHGA
227 adrenal cortical carcinoma 9.8 SYP MUC1 CHGA
228 perivascular epithelioid cell tumor 9.8 SYP MUC1 CDKN2A
229 choroid plexus cancer 9.8 SYP CEACAM5
230 glomus tumor 9.8 SYP MUC1 CDKN2A
231 rhabdoid cancer 9.8 SYP MUC1 CDKN2A
232 neurofibroma 9.8 SYP MUC1 CDKN2A
233 gastrointestinal carcinoma 9.8 MUC1 CEACAM5
234 nodular hidradenoma 9.8 PIP MUC1 CEACAM5
235 hidradenoma 9.8 PIP MUC1 CEACAM5
236 paget disease, extramammary 9.8 PIP MUC1 CEACAM5
237 vulvar disease 9.8 PIP CEACAM5 CDKN2A
238 thoracic benign neoplasm 9.8 PIP MUC1 CEACAM5
239 breast benign neoplasm 9.8 PIP MUC1 CEACAM5
240 papillary adenocarcinoma 9.8 PIP MUC1 CEACAM5
241 vulva cancer 9.8 PIP CEACAM5 CDKN2A
242 small intestine cancer 9.7 MUC1 CEACAM5
243 lymphohistiocytoid mesothelioma 9.7 PTGER4 CEACAM5 CDKN2A
244 benign peritoneal mesothelioma 9.7 PTGER4 MUC1 CEACAM5
245 peritoneum cancer 9.7 PTGER4 CEACAM5 CDKN2A
246 ampulla of vater cancer 9.7 MUC1 CEACAM5
247 gastrointestinal stromal tumor 9.7 SYP CHGA CDKN2A
248 ewing sarcoma 9.7 SYP CHGA CDKN2A
249 sweat gland cancer 9.7 SYP PIP CEACAM5
250 peritoneal serous adenocarcinoma 9.7 SYP PTGER4 PIP CHGA
251 malignant exocrine pancreas neoplasm 9.7 MUC1 CEACAM5 CDKN2A
252 peritoneal mesothelioma 9.7 MUC1 CEACAM5 CDKN2A
253 ovarian cystadenocarcinoma 9.7 MUC1 CEACAM5 CDKN2A
254 endocervical adenocarcinoma 9.7 MUC1 CEACAM5 CDKN2A
255 mucinous adenocarcinoma 9.7 MUC1 CEACAM5 CDKN2A
256 ovary adenocarcinoma 9.7 MUC1 CEACAM5 CDKN2A
257 pancreatic serous cystadenocarcinoma 9.7 SYP CHGA CEACAM5
258 gastric small cell carcinoma 9.7 SYP CHGA CEACAM5
259 malignant ovarian surface epithelial-stromal neoplasm 9.7 MUC1 CEACAM5 CDKN2A
260 colorectal adenocarcinoma 9.7 MUC1 CEACAM5 CDKN2A
261 esophageal adenoid cystic carcinoma 9.7 SYP CHGA CEACAM5
262 ovary epithelial cancer 9.7 MUC1 CEACAM5 CDKN2A
263 meningioma, familial 9.7 SYP MUC1 CDKN2A
264 colon neuroendocrine neoplasm 9.7 SYP CHGA CEACAM5
265 mediastinal cancer 9.7 SYP CHGA CEACAM5
266 mesothelioma, malignant 9.7 MUC1 CEACAM5 CDKN2A
267 cecal disease 9.7 SYP CHGA CEACAM5
268 thyroid gland medullary carcinoma 9.7 SYP CHGA CEACAM5
269 pancreatic cystadenoma 9.7 SYP CHGA CEACAM5
270 multiple endocrine neoplasia, type iia 9.7 SYP CHGA CEACAM5
271 cardiovascular organ benign neoplasm 9.7 SYP CHGA CEACAM5
272 actinic keratosis 9.6 CEACAM5 CDKN2A
273 vulva basal cell carcinoma 9.6 SYP CEACAM5 CDKN2A
274 papillary squamous carcinoma 9.6 SYP CEACAM5 CDKN2A
275 biliary tract benign neoplasm 9.6 SYP MUC1 CEACAM5
276 keratinizing squamous cell carcinoma 9.6 SYP CEACAM5 CDKN2A
277 bile duct cancer 9.6 MUC1 CEACAM5 CDKN2A
278 thymic carcinoma 9.6 SYP MUC1 CEACAM5
279 thyroid gland cancer 9.6 SYP CHGA CEACAM5
280 adenoma 9.5 SYP MUC1 CHGA CDKN2A
281 small cell carcinoma 9.5 SYP MUC1 CHGA CDKN2A
282 merkel cell carcinoma 9.5 SYP MUC1 CHGA CDKN2A
283 malignant spiradenoma 9.5 PTGER4 PIP CEACAM5 CDKN2A
284 borst-jadassohn intraepidermal carcinoma 9.5 PTGER4 PIP CEACAM5 CDKN2A
285 signet ring cell adenocarcinoma 9.5 PIP MUC1 CHGA CEACAM5
286 thyroid carcinoma, familial medullary 9.5 CHGA CEACAM5
287 cystic basal cell carcinoma 9.5 SYP PTGER4 PIP CEACAM5
288 lung cancer susceptibility 3 9.5 PIP MUC1 CEACAM5 CDKN2A
289 papillary thymic adenocarcinoma 9.4 SYP PTGER4 CHGA CEACAM5
290 mucoepidermoid carcinoma 9.4 MUC1 CHGA CEACAM5 CDKN2A
291 vaginal tubulovillous adenoma 9.4 SYP CHGA CEACAM5 CDKN2A
292 tubular adenocarcinoma 9.4 SYP MUC1 CHGA CEACAM5
293 benign teratoma 9.4 SYP MUC1 CHGA CEACAM5
294 basal cell carcinoma 9.4 SYP CHGA CEACAM5 CDKN2A
295 cystadenoma 9.4 SYP MUC1 CHGA CEACAM5
296 teratoma 9.4 SYP CHGA CEACAM5 CDKN2A
297 large cell carcinoma 9.4 SYP MUC1 CHGA CEACAM5
298 neuroendocrine carcinoma 9.4 SYP MUC1 CHGA CEACAM5
299 small cell cancer of the lung 9.4 SYP CHGA CEACAM5 CDKN2A
300 cell type benign neoplasm 9.4 SYP CHGA CEACAM5 CDKN2A
301 adenosquamous carcinoma 9.3 SYP MUC1 CEACAM5 CDKN2A
302 skin carcinoma 9.0 SYP PTGER4 PIP CHGA CEACAM5 CDKN2A

Graphical network of the top 20 diseases related to Vulvar Eccrine Porocarcinoma:



Diseases related to Vulvar Eccrine Porocarcinoma

Symptoms & Phenotypes for Vulvar Eccrine Porocarcinoma

Drugs & Therapeutics for Vulvar Eccrine Porocarcinoma

Search Clinical Trials , NIH Clinical Center for Vulvar Eccrine Porocarcinoma

Genetic Tests for Vulvar Eccrine Porocarcinoma

Anatomical Context for Vulvar Eccrine Porocarcinoma

Publications for Vulvar Eccrine Porocarcinoma

Articles related to Vulvar Eccrine Porocarcinoma:

(showing 3, show less)
# Title Authors PMID Year
1
Vulvar eccrine porocarcinoma: report of a case and literature review. 61
29556664 2017
2
Eccrine porocarcinoma of the vulva: a case report and review of the literature. 61
27832810 2016
3
Vulvar eccrine porocarcinoma. 61
8812539 1996

Variations for Vulvar Eccrine Porocarcinoma

Expression for Vulvar Eccrine Porocarcinoma

Search GEO for disease gene expression data for Vulvar Eccrine Porocarcinoma.

Pathways for Vulvar Eccrine Porocarcinoma

Pathways related to Vulvar Eccrine Porocarcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 10.21 MUC1 CEACAM5

GO Terms for Vulvar Eccrine Porocarcinoma

Sources for Vulvar Eccrine Porocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....